Hereditary breast cancer: from molecular pathology to tailored therapies

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Pathology

• Publication date

  2008-08-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jcp.2008.057950PMID 18682420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma‐derived cell lines

  2009cited by this paper
• Hereditary ovarian cancer.

  2009cited by this paper
• A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer

  2009cited by this paper
• Resistance to therapy caused by intragenic deletion in BRCA2

  2008cited by this paper
• Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.

  2008cited by this paper
• A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair.

  2008cited by this paper
• High frequency of HIF-1α overexpression in BRCA1 related breast cancer

  2008cited by this paper
• Development of therapeutic approaches to ‘triple negative’ phenotype breast cancer

  2008cited by this paper
• Expression of BRCA1 protein in breast cancer and its prognostic significance.

  2008cited by this paper
• Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

  2008cited by this paper
• Nijmegen Breakage Syndrome mutations and risk of breast cancer

  2008cited by this paper
• High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.

  2008cited by this paper
• NBS1 variant I171V and breast cancer risk

  2008cited by this paper
• Ductal carcinoma in situ in BRCA mutation carriers.

  2007cited by this paper
• The emerging landscape of breast cancer susceptibility

  2007cited by this paper
• Analysis of PALB2/FANCN-associated breast cancer families

  2007cited by this paper
• Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families

  2007cited by this paper
• Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

  2007cited by this paper
• Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players.

  2007cited by this paper
• Fanconi anemia is associated with a defect in the BRCA2 partner PALB2

  2007cited by this paper
• BRCA1 dysfunction in sporadic basal-like breast cancer

  2007cited by this paper
• A mouse model of basal‐like breast carcinoma with metaplastic elements

  2007cited by this paper
• Germline E-cadherin mutations in familial lobular breast cancer

  2007cited by this paper
• Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

  2007cited by this paper
• Nijmegen breakage syndrome.

  2007cited by this paper
• PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

  2007cited by this paper
• BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays

  2007cited by this paper
• Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer

  2007cited by this paper
• BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy

  2007cited by this paper
• An Immunohistochemical Study

  2006cited by this paper
• Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data

  2006cited by this paper
• Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations

  2006cited by this paper
• Metaplastic breast carcinomas are basal‐like tumours

  2006cited by this paper
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper
• Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

  2006cited by this paper
• Histopathological features of breast cancer in carriers of ATM gene variants

  2006cited by this paper
• Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas

  2006cited by this paper
• The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

  2006cited by this paper
• Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer

  2006cited by this paper
• Morphology of Breast Cancer as a Means of Triage of Patients for BRCA1 Genetic Testing

  2006cited by this paper
• Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.

  2006cited by this paper
• Evaluation of RAD50 in familial breast cancer predisposition

  2006cited by this paper
• Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

  2006cited by this paper
• Basal-like breast cancer and the BRCA1 phenotype

  2006cited by this paper
• Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer

  2006cited by this paper
• The CHEK2 gene and inherited breast cancer susceptibility

  2006cited by this paper
• Mutation analysis of five candidate genes in familial breast cancer

  2006cited by this paper
• Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families

  2005cited by this paper
• Targeting the DNA repair defect of BRCA tumours.

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Hereditary ovarian cancer.

  2005cited by this paper
• BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-ribose) polymerase: An issue of potency

  2005cited by this paper
• Exploiting the DNA repair defect in BRCA mutant cells in the design of new therapeutic strategies for cancer.

  2005cited by this paper
• Germline BRCA 1 Mutations and Loss of the Wild-Type Allele in Tumors from Families with Early Onset Breast and Ovarian Cancer 1

  2005cited by this paper
• Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer

  2005cited by this paper
• Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.

  2005cited by this paper
• Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

  2005cited by this paper
• Pathology of breast cancer in women with constitutional CHEK2 mutations

  2005cited by this paper
• Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibition

  2005cited by this paper
• Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

  2005cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

  2005cited by this paper
• BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles

  2005cited by this paper
• The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications

  2005cited by this paper
• Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.

  2005cited by this paper
• Oh what a tangled web it weaves: BRCA1 and DNA decatenation.

  2005cited by this paper
• Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.

  2005cited by this paper
• The role of BRCA1 in the cellular response to chemotherapy.

  2004cited by this paper
• Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer

  2004cited by this paper
• ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers

  2004cited by this paper
• Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

  2004cited by this paper
• Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

  2004cited by this paper
• Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• Amplification of the BRCA2 Pathway Gene EMSY in Sporadic Breast Cancer Is Related to Negative Outcome

  2004cited by this paper
• Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• Mutation analysis of five candidate genes in Chinese patients with hypospadias

  2004cited by this paper
• ATM and ataxia telangiectasia

  2004cited by this paper
• BRCA1 and BRCA2: 1994 and beyond

  2004cited by this paper
• Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.

  2004cited by this paper
• Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

  2004cited by this paper
• Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.

  2003cited by this paper
• Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

  2003cited by this paper
• EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Improved survival in women with BRCA‐associated ovarian carcinoma

  2003cited by this paper
• Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation

  2003cited by this paper
• The BRCT Domain Is a Phospho-Protein Binding Domain

  2003cited by this paper
• The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

  2002cited by this paper
• Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.

  2002cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• HER‐2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

  2002cited by this paper
• Biallelic Inactivation of BRCA2 in Fanconi Anemia

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• Model‐based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center

  2002cited by this paper
• Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1

  2001cited by this paper
• [Nijmegen breakage syndrome].

  2001cited by this paper
• Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.

  2001cited by this paper

• Multisite Chronic Pain and the Risk of Breast Cancer and Its Subtypes: A Mendelian Randomization Study

  2025cites this paper
• Preliminary investigation of MMP8 (rs11225395) and MMP9 (rs3787268) polymorphisms association with breast cancer risk in pashtun women of Pakistan

  2024cites this paper
• Alternaria alternata (SDHY01/02), a fungus associated with Lamellodysidea herbacea: its anticancer potential and responsible constituent(s)

  2023cites this paper
• Estimation of associations between MMP9 gene polymorphisms and breast cancer: Evidence from a meta-analysis

  2022cites this paper
• Perioperative renal protection

  2021cites this paper
• Microbial cancer therapeutics: A promising approach.

  2021cites this paper
• Association of polymorphisms in LOC105377871 and CASC16 with breast cancer in the northwest Chinese Han population

  2020cites this paper
• Tumor Microenvironment

  2020cites this paper
• Germline Genetic Testing in Prostate Cancer, a Potential for New Understanding Screening, Evaluation and Treatment of Prostate Cancer

  2020cites this paper
• IL-7R gene variants are associated with breast cancer susceptibility in Chinese Han women.

  2020cites this paper
• The Immune Landscape in Women Cancers.

  2020cites this paper
• Correlation between IL‐7R gene variants and breast cancer susceptibility in Chinese Han women

  2020cites this paper
• Marine Natural Products: A Source of Novel Anticancer Drugs

  2019cites this paper
• Association of CAV1 polymorphisms with the risks of breast cancer: A systematic review and meta-analysis.

  2019cites this paper
• A study on estrogen and progesterone receptor status in fine needle aspirates of breast carcinoma: comparison of the immunohistochemical expression of ER PR in cell block and biopsy

  2018cites this paper
• Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women

  2018cites this paper
• Diagnosis Of Breast Carcinoma on Fine Needle Aspiration Cytology – An Institutional Based Study

  2017cites this paper
• Genetic polymorphisms in caveolin-1 associate with breast cancer risk in Chinese Han population

  2017cites this paper
• Antitumor activity of extract and isolated compounds from Drechslera rostrata and Eurotium tonophilum

  2017cites this paper
• Tristetraprolin: a novel mediator of the anticancer properties of resveratrol.

  2016cites this paper
• To Assess the Stromal Expression of CD10 in InvasiveDuctal Carcinoma of Breast and It’s Correlation withHistological Grade, ER, PR AND HER2/neu Expression

  2016cites this paper
• Clinical Implications of Risk and Prognostic Factors in Patients with Breast Carcinomas

  2015cites this paper
• Genotype and Phenotype Correlation of Breast Cancer in BRCA MutationCarriers and Non-Carriers

  2015cites this paper
• WT1 role in mammary gland and breast cancer biology

  2015cites this paper
• Hereditary Breast Cancer: Clinical, Pathological and Molecular Characteristics

  2014cites this paper
• Are mammaglobin and GCDFP-15 sensitive markers for diagnosis of metastatic basal-like triple negative breast carcinomas?

  2014cites this paper
• ANTICANCER ACTIVITY OF COMPOUNDS ISOLATED FROM MARINE ENDOPHYTIC FUNGUS ASPERGILLUS TERREUS

  2014cites this paper
• Are Mammaglobin and Gcdfp-15 Sensitive Markers for Diagnosis of Metastatic Basal-Like Triple Negative Breast Carcinomas? / Mammaglobin ve GCDFP-15 Metastatik Üçlü Negatif Meme Kanserlerinin Tanısı İçin Duyarlı Belirleyiciler midir?

  2014cites this paper
• How our practice of histopathology, especially tumour pathology has changed in the last two decades: reflections from a major referral center in Pakistan.

  2014cites this paper
• Enhancement of Chronically Induced Breast Carcinogenesis by Combined Environmental and Dietary Carcinogens and Suppression by Dietary Agents

  2014cites this paper
• MicroRNA expression signatures for the prediction of BRCA1/2 mutation‐associated hereditary breast cancer in paraffin‐embedded formalin‐fixed breast tumors

  2014cites this paper
• A Comprehensive Literature Analysis of Causes and Treatment Options for Hereditary Breast Cancer

  2013cites this paper
• Male breast cancer: genetics, epigenetics, and ethical aspects.

  2013cites this paper
• Aspects of Penicillium genomics : Molecular combing genome assembly, genetic exchange in food and potential for secondary metabolite production

  2013cites this paper
• Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas

  2012cites this paper
• Potential anticancer activity of the medicinal herb, Rhazya stricta, against human breast cancer

  2012cites this paper
• MicroRNA expression profiles in hereditary breast cancer

  2012cites this paper
• The role of BRCA1 and BRCA2 in prostate cancer.

  2012cites this paper
• Pathology of hereditary breast cancer

  2011cites this paper
• Pathology of hereditary breast cancer

  2011cites this paper
• PALB2 mutations in familial breast and pancreatic cancer

  2011cites this paper
• Data mining techniques and breast cancer prediction : a case study of Libya

  2011cites this paper
• Targeting triple-negative sporadic and hereditary BRCA-related metastatic breast cancer

  2011cites this paper
• Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas

  2011cites this paper
• Homozygous deficiency of ubiquitin-ligase ring-finger protein RNF168 mimics the radiosensitivity syndrome of ataxia-telangiectasia

  2011cites this paper
• Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia

  2011cites this paper
• Phenotype-Genotype Correlation in Familial Breast Cancer

  2011cites this paper
• Methylation profiles of hereditary and sporadic ovarian cancer

  2010cites this paper
• Lynch Syndrome–Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry

  2010cites this paper
• Targeting the DNA double strand breaks repair for cancer therapy.

  2010cites this paper
• Methylation markers for early breast cancer detection

  2010cites this paper
• Variants in the ATM Gene Associated with a Reduced Risk of Contralateral Breast Cancer: Concannon P, Haile RW, Børresen-Dale A-L, et al (Univ of Virginia, Charlottesville; Univ of Southern California; Univ of Oslo, Norway; et al) Cancer Res 68:6486-6491, 2008§

  2009cites this paper
• Hereditary Breast Cancer and Hereditary Non-Polyposis Colorectal Cancer: Description of Two Families, as the Examples of Classical Hereditary Predisposition to Cancers

  2009cites this paper
• BRCA1 and BRCA2: Role in the DNA Damage Response, Cancer Formation and Treatment

  2009cites this paper
• A Review of the Molecular Mechanisms of Chemically Induced Neoplasia in Rat and Mouse Models in National Toxicology Program Bioassays and Their Relevance to Human Cancer

  2009cites this paper
• Genetic characterization of breast cancer and implications for clinical management

  2009cites this paper
• GENERAL ASPECTS AND IMAGING TECHNIQUES

  2009cites this paper
• Oral Contraceptive Use and BRCA Penetrance: A Case-Only Study

  2009cites this paper
• The role of molecular analysis in breast cancer

  2009cites this paper
• SELECÇÃO DAS MULHERES COM CRITÉRIOS PARA A PESQUISA DE MUTAÇÃO BRCA1/BRCA2 NO CENTRO HOSPITALAR DO PORTO

  2009cites this paper
• Genetic Theory of Cancer. Short Review

  2009cites this paper
• Genomic instability in the breast microenvironment? A critical evaluation of the evidence

  2009cites this paper
• Triple negative and basal-like breast cancer : one or many diseases ? Implications for surgical pathologists

  2009cites this paper
• SOCIETY COMPANION MEETING : DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY

  2009cites this paper
• The Application of Clinical Genetics Dovepress Inherited and Acquired Alterations in Development of Breast Cancer

  year unknowncites this paper
• REVIEW How Our Practice of Histopathology, Especially Tumour Pathology has Changed in the Last Two Decades: Reflections from a Major Referral Center in Pakistan

  year unknowncites this paper